[A case of metastatic breast cancer with bilateral hydronephrosis effectively treated with capecitabine].
Gan To Kagaku Ryoho
; 39(12): 2077-9, 2012 Nov.
Article
en Ja
| MEDLINE
| ID: mdl-23267982
ABSTRACT
A 54-year-old female was diagnosed with invasive ductal carcinoma (pT3N1M0, Stage IIIA, estrogen receptor positive [ER (+)], progesterone receptor positive [PgR (+)], human epidermal growth factor receptor type 2 [HER2] score 0) and was treated by preoperative chemotherapy with weekly paclitaxel followed by 5-fluorouracil(5-FU) plus epirubicin plus cyclophosphamide regimen(FEC). Partial mastectomy with axillary dissection was performed. The pathological examination disclosed that the tumor was scirrhous carcinoma, and a pathological partial response was achieved by chemotherapy. Multiple bone metastases were detected 18 months after the surgery during treatment with letrozole as adjuvant therapy. Retroperitoneal metastases with hydronephrosis and a lung metastasis were detected 28 months after the surgery, even though exemestane and zoledronate were administrated after detection of the bone metastases. Chemotherapy with capecitabine was started and she recovered from hydronephrosis 4 months after the start of treatment. After 32 months from the first treatment with capecitabine, the patient is presently alive without hydronephrosis due to continued chemotherapy.
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Neoplasias Peritoneales
/
Neoplasias de la Mama
/
Adenocarcinoma Escirroso
/
Desoxicitidina
/
Fluorouracilo
/
Hidronefrosis
/
Antimetabolitos Antineoplásicos
Límite:
Female
/
Humans
/
Middle aged
Idioma:
Ja
Año:
2012
Tipo del documento:
Article